FDA lowers starting dose for sleeping aid Lunesta - FOX 10 News | fox10phoenix.com

FDA lowers starting dose for sleeping aid Lunesta

Posted: Updated:

By MATTHEW PERRONE AP Health Writer

WASHINGTON (AP) -- U.S. health officials are lowering the starting dose of the popular sleeping aid drug Lunesta, due to risks of morning drowsiness that can impair driving ability and lead to injury.

The Food and Drug Administration said Thursday it is taking action based on a study that found Lunesta users had problems with driving, memory and coordination up to 11 hours after first taking the drug. Patients are often unaware that they are still drowsy the morning after, according to the FDA, which monitors food and drugs for safety.

The results, published last month, compared 91 patients taking Lunesta or placebo while performing several tasks measuring coordination, memory and other cognitive measures.

Lunesta manufacturer Sunovion Pharmaceuticals, a subsidiary of Japanese drugmaker Dainippon Sumitomo Pharma, will lower the starting dose of the tablet to 1 milligram from currently available 2 milligrams. Patients can increase their dose to 2 or 3 milligrams, but should keep in mind that higher doses are more likely to cause next-day impairment, according to the FDA statement.

Patients currently taking 2 or 3 milligram doses of Lunesta should contact their doctor to get information about the most appropriate dose.

Drowsiness is a side effect listed on the labels of all anti-insomnia drugs, the agency release notes.

Thursday's announcement follows a similar FDA action last year that reduced the dosage of Ambien and other generic insomnia drugs containing the ingredient zolpidem. Those drugs are the most widely prescribed sleep aids in the U.S. Lunesta uses a different active ingredient called eszopiclone.

"Recently, data from clinical trials and other types of studies have become available, which allowed the FDA to better characterize the risk of next-morning impairment with sleep drugs," the FDA's Dr. Ellis Unger said in a statement.

Lunesta, launched in 2005, is designed to be taken before bed to help patients with insomnia fall asleep and stay asleep for up to 7 hours.

Calls to Sunovion Pharmaceuticals Inc. were not immediately returned Thursday afternoon.

Copyright 2014 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

  • HealthMore>>

  • Diabetes May Slow the Middle-Aged Brain

    Diabetes May Slow the Middle-Aged Brain

    Diabetes May Slow the Middle-Aged Brain Type 2 diabetes in those ages 50 to 65 may increase the likelihood of mild cognitive impairment (dailyRx News) As people age, their brains may not work at full speed. For...
    Diabetes May Slow the Middle-Aged Brain Type 2 diabetes in those ages 50 to 65 may increase the likelihood of mild cognitive impairment (dailyRx News) As people age, their brains may not work at full...
  • Overall US Dietary Quality Remained Low

    Overall US Dietary Quality Remained Low

    Overall US Dietary Quality Remained Low Higher socioeconomic status associated with a healthier diet (dailyRx News) Since 2000, US officials have made several policy changes in nutrition and proper food processing....
    Overall US Dietary Quality Remained Low Higher socioeconomic status associated with a healthier diet (dailyRx News) Since 2000, US officials have made several policy changes in nutrition and proper food...
  • Report: health risks at some nail salons

    Report: health risks at some nail salons

    Monday, September 15 2014 10:28 PM EDT2014-09-16 02:28:27 GMT
    One of the most surprising findings in a report from the New York City public advocate is that city officials have virtually no authority over how nail salons are run. The city can't enforce standards like they do with restaurants, so it's clearly a case of beauty buyer beware. We get our nails done without thinking too much about it.
    One of the most surprising findings in a report from the New York City public advocate is that city officials have virtually no authority over how nail salons are run. The city can't enforce standards like they do with restaurants, so it's clearly a case of beauty buyer beware. We get our nails done without thinking too much about it.
Powered by WorldNow

KSAZ-TV & KUTP
511 W. Adams St.
Phoenix, AZ 85003

Phone: (602) 257-1234
Fax: (602) 262-0177

Didn't find what you were looking for?
All content © Copyright 2000 - 2014 Fox Television Stations, Inc. and Worldnow. All Rights Reserved.
Privacy Policy | New Terms of Service What's new | Ad Choices